Ryutaro Hirose

7.2k total citations · 3 hit papers
140 papers, 4.9k citations indexed

About

Ryutaro Hirose is a scholar working on Surgery, Hepatology and Transplantation. According to data from OpenAlex, Ryutaro Hirose has authored 140 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Surgery, 50 papers in Hepatology and 39 papers in Transplantation. Recurrent topics in Ryutaro Hirose's work include Organ Transplantation Techniques and Outcomes (58 papers), Liver Disease and Transplantation (45 papers) and Renal Transplantation Outcomes and Treatments (36 papers). Ryutaro Hirose is often cited by papers focused on Organ Transplantation Techniques and Outcomes (58 papers), Liver Disease and Transplantation (45 papers) and Renal Transplantation Outcomes and Treatments (36 papers). Ryutaro Hirose collaborates with scholars based in United States, South Korea and Japan. Ryutaro Hirose's co-authors include John P. Roberts, Francis Y. Yao, Chris E. Freise, Claus U. Niemann, Nancy L. Ascher, Robert K. Kerlan, Peter G. Stock, Neil Mehta, Jennifer L. Dodge and Sandy Feng and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ryutaro Hirose

136 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteria

2015 325 citations Francis Y. Yao, Neil Mehta et al. profile →
OPTN/SRTR 2019 Annual Data Report: Kidney

2021 268 citations Allyson Hart, Ajay K. Israni et al. American Journal of Transplantation profile →
OPTN/SRTR 2020 Annual Data Report: Kidney

2022 230 citations Allyson Hart, Jonathan Miller et al. American Journal of Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryutaro Hirose United States	36	2.4k	2.2k	1.4k	1.2k	762	140	4.9k
Johnny C. Hong United States	37	3.8k 1.6×	3.0k 1.4×	1.4k 1.0×	856 0.7×	698 0.9×	105	5.2k
Chris E. Freise United States	39	3.2k 1.3×	3.0k 1.4×	1.4k 1.0×	1.1k 0.9×	1.4k 1.8×	128	5.5k
Derek Manas United Kingdom	39	2.4k 1.0×	1.7k 0.8×	1.2k 0.9×	809 0.7×	732 1.0×	199	5.1k
Silvio Nadalin Germany	38	3.2k 1.3×	3.2k 1.5×	1.5k 1.0×	498 0.4×	704 0.9×	215	5.3k
David Roth United States	44	1.8k 0.8×	1.6k 0.7×	1.5k 1.1×	2.9k 2.3×	689 0.9×	178	6.2k
Luiz Augusto Carneiro D’Albuquerque Brazil	30	1.9k 0.8×	1.6k 0.7×	1.1k 0.8×	438 0.4×	345 0.5×	336	3.8k
Franco Filipponi Italy	39	3.2k 1.3×	2.1k 1.0×	1.3k 0.9×	586 0.5×	323 0.4×	230	5.3k
William Irish United States	45	3.7k 1.6×	1.8k 0.8×	1.8k 1.2×	3.0k 2.4×	1.2k 1.6×	190	8.0k
Christophe Duvoux France	41	2.7k 1.1×	4.1k 1.9×	2.6k 1.8×	1.4k 1.2×	221 0.3×	142	6.0k
Pål‐Dag Line Norway	35	2.6k 1.1×	1.8k 0.8×	683 0.5×	869 0.7×	997 1.3×	201	4.8k

Countries citing papers authored by Ryutaro Hirose

Since Specialization

Citations

This map shows the geographic impact of Ryutaro Hirose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryutaro Hirose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryutaro Hirose more than expected).

Fields of papers citing papers by Ryutaro Hirose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryutaro Hirose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryutaro Hirose. The network helps show where Ryutaro Hirose may publish in the future.

Co-authorship network of co-authors of Ryutaro Hirose

This figure shows the co-authorship network connecting the top 25 collaborators of Ryutaro Hirose. A scholar is included among the top collaborators of Ryutaro Hirose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryutaro Hirose. Ryutaro Hirose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Hidenori, Saori Shimizu, Takahiko Yano, et al.. (2025). Trends in Group A Streptococcus Pharyngitis and Co-Infection with Severe Acute Respiratory Syndrome Coronavirus 2: A Retrospective Observational Study. Medicina. 61(5). 937–937.

Lyden, Grace R., Maryam Valapour, Nicholas L. Wood, et al.. (2025). Impact of the lung allocation system score modification by blood type on US lung transplant candidates. American Journal of Transplantation. 25(6). 1208–1217. 2 indexed citations

Schladt, David P., Nicole Gladish, Ava Kwong, et al.. (2025). Insurance and Cause of End-Stage Liver Disease Attenuate Association of SDI on Time to Liver Transplant. American Journal of Transplantation. 25(8). S534–S534.

Hoffman, Daniel, Amir Ashraf‐Ganjouei, Alexa Glencer, et al.. (2024). Graft choice in pancreatectomy with vascular resection: equivalent safety in selected patients. Journal of Gastrointestinal Surgery. 28(11). 1799–1804.

Lin, Shin, Ioannis Dimarakis, Elina Minami, et al.. (2024). Highly sensitized patients listed for heart after liver transplantation with or without domino. The Journal of Heart and Lung Transplantation. 44(1). 125–128. 2 indexed citations

Miller, Jonathan, David Zaun, Nicholas L. Wood, et al.. (2024). Adjusting for race in metrics of organ procurement organization performance. American Journal of Transplantation. 24(8). 1440–1444. 4 indexed citations

Takahashi, Hidenori, Miwa Morikawa, Ryutaro Hirose, et al.. (2024). Diagnostic utility of pharyngeal follicular structures in COVID-19: A large-scale cross-sectional study. International Journal of Infectious Diseases. 149. 107244–107244. 1 indexed citations

Meier, Raphaël, Shareef Syed, Sandy Feng, et al.. (2023). DCD liver transplant in patients with a MELD over 35. Frontiers in Immunology. 14. 1246867–1246867. 3 indexed citations

Miller, Jonathan, Yoon Son Ahn, Allyson Hart, et al.. (2023). OPTN/SRTR 2021 Annual Data Report: COVID-19. American Journal of Transplantation. 23(2). S475–S522. 5 indexed citations

10.

Meier, Raphaël, Yvonne Kelly, Seiji Yamaguchi, et al.. (2022). Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation. Frontiers in Surgery. 8. 808733–808733. 6 indexed citations

11.

Hirose, Ryutaro, Francis Y. Yao, Chengshi Jin, et al.. (2021). The Impact of Median Model for End‐Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma. Liver Transplantation. 28(3). 376–385. 14 indexed citations

12.

Braun, Hillary J., et al.. (2020). Implementing an opioid reduction protocol in renal transplant recipients. The American Journal of Surgery. 220(5). 1284–1289. 12 indexed citations

13.

Braun, Hillary J., Chengshi Jin, Dominic Amara, et al.. (2020). Opioid use prior to liver transplant is associated with increased risk of death after transplant. The American Journal of Surgery. 222(1). 234–240. 5 indexed citations

14.

Brondfield, Max N., Jennifer L. Dodge, Ryutaro Hirose, et al.. (2019). Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short‐Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change. Liver Transplantation. 26(5). 662–672. 11 indexed citations

15.

Mehta, Neil, Jennifer L. Dodge, Ryutaro Hirose, John P. Roberts, & Francis Y. Yao. (2018). Increasing Liver Transplantation Wait‐List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation. Liver Transplantation. 24(10). 1346–1356. 43 indexed citations

16.

Mehta, Neil, Jennifer L. Dodge, John P. Roberts, Ryutaro Hirose, & Francis Y. Yao. (2017). Misdiagnosis of hepatocellular carcinoma in patients receiving no local‐regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clinical Transplantation. 31(11). 8 indexed citations

17.

Hart, Allyson, David P. Schladt, Joshua Pyke, et al.. (2016). Predicting Outcomes on the Liver Transplant Waiting List in the United States. Transplantation. 100(10). 2153–2159. 28 indexed citations

18.

Niemann, Claus U., Ann Walia, Jeffrey Waldman, et al.. (2009). Acute Kidney Injury During Liver Transplantation as Determined by Neutrophil Gelatinase-Associated Lipocalin. Liver Transplantation. 15(12). 1852–1860. 103 indexed citations

19.

Hirose, Ryutaro, Fengyun Xu, Kim Dang, et al.. (2008). Transient Hyperglycemia Affects the Extent of Ischemia-Reperfusion-induced Renal Injury in Rats. Anesthesiology. 108(3). 402–414. 48 indexed citations

20.

Behrends, Matthias, Ryutaro Hirose, Yeon Ho Park, et al.. (2007). Remote Renal Injury Following Partial Hepatic Ischemia/Reperfusion Injury in Rats. Journal of Gastrointestinal Surgery. 12(3). 490–495. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact